RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FUSCO V
Collezione AOU Alessandria

Items : 45

Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ). in Oral diseases / Oral Dis. 2024 Sep;30(6):3679-3709. doi: 10.1111/odi.14887. Epub 2024 Feb 5.

2024
AOU Alessandria

Vescovi P; Campisi G; Saia G; Panzarella V; Marchetti C; Bettini G; Di Fede O; Lo Casto A; Bertoldo F; Fusco V; Mauceri R; Bedogni A;

Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?". in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA / Osteoporos Int. 2024 Nov;35(11):2071-2072. doi: 10.1007/s00198-024-07192-4. Epub 2024 Aug 16.

2024
AOU Alessandria

Campisi G; Mauceri R; Coppini M; Bedogni A; Bertoldo F; Fusco V;

Correction: Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?". in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA / Osteoporos Int. 2024 Nov;35(11):2073. doi: 10.1007/s00198-024-07245-8.

2024
AOU Alessandria

Campisi G; Mauceri R; Coppini M; Bedogni A; Bertoldo F; Fusco V;

Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2024 Mar 1;32(3):202. doi: 10.1007/s00520-024-08392-8.

2024
ASL Asti
AOU Alessandria
AO Ordine Mauriziano

Cinieri S; Comandone A; Airoldi M; Rossi M; Rossetti G; Lanzetta G; Cavanna L; Bossi P; Ibrahim T; De Giorgi U; Tucci M; Santini D; Fusco V; Di Maio M; Valsecchi AA;

Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey. in Tumori / Tumori. 2024 Jun;110(3):174-185. doi: 10.1177/03008916241236279. Epub 2024 Mar 10.

2024
ASL Asti
AOU Alessandria
AO Ordine Mauriziano

Cinieri S; Vignani F; Valsecchi AA; Fusco V; Dionisio R; De Giorgi U; Di Maio M; Santini D; Tucci M;

MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series. in BMC oral health / BMC Oral Health. 2023 Feb 4;23(1):71. doi: 10.1186/s12903-023-02732-6.

2023
AOU Alessandria
ASL Alessandria

Oteri G; Campisi G; Toro C; Isola G; Leonardi RM; Giudice A; Graziani F; Marcianò A; Nisi M; Bettini G; Fusco V; Attanasio M; Bedogni A; Coppini M; Mauceri R;

Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw. in International journal of molecular sciences / Int J Mol Sci. 2023 Apr 27;24(9):7948. doi: 10.3390/ijms24097948.

2023
AOU Alessandria

Fusco V; Mussano F; Roato I; Mauceri R; Notaro V; Genova T;

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ). in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2022 Sep;30(9):7047-7051. doi: 10.1007/s00520-022-06982-y. Epub 2022 Mar 21.

2022
ASL Alessandria
AOU Alessandria

Fusco V; Bedogni A; Campisi G;

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. in The Lancet. Oncology / Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X. Epub 2022 Jun 2.

2022
AOU Alessandria
AOU Novara

Cortellini A; Gennari A; Tabernero J; Mukherjee U; Diamantis N; Fusco V; Generali D; Provenzano S; Grisanti S; Libertini M; Prat A; Tucci M; Rimassa L; Aujayeb A; Grosso F; Parisi A; Queirolo P; Mazzoni F; Caliman E; Santoro A; Giusti R; Zambelli A; Cantini L; Martinez-Vila C; Patriarca A; Gaidano G; Ruiz-Camps I; Bruna R; Fox L; et alii...

Prognosis of metastatic bone cancer and myeloma patients and long-term risk of medication-related osteonecrosis of the jaw (MRONJ): some critical points. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2022 Dec;30(12):9707-9709. doi: 10.1007/s00520-022-07214-z. Epub 2022 Jul 27.

2022
AOU Alessandria

Palmeri S; Gambino A; Fasciolo A; Rossi M; Fusco V;

The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2022 Aug;30(8):6429-6440. doi: 10.1007/s00520-022-06940-8. Epub 2022 Mar 16.

2022
ASL Alessandria
AOU Alessandria

Campisi G; Panzarella V; Mauceri R; Coniglio R; Abbinante A; Carcieri P; Fusco V; Bedogni A; Bertoldo F; Di Fede O; Tomassi D;

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Aug;171:64-74. doi: 10.1016/j.ejca.2022.04.036. Epub 2022 May 23.

2022
AOU Alessandria
AOU Novara

Tabernero J; Gennari A; Cortellini A; Rimassa L; Prat A; Aujayeb A; Queirolo P; Parisi A; Filetti M; Mazzoni F; Santoro A; Delfanti S; Martinez-Vila C; Berardi R; Fusco V; Shawe-Taylor M; Patriarca A; Zoratto F; Gaidano G; Ruiz-Camps I; Bruna R; Roldán E; Fox L; Doonga K; Saoudi-Gonzalez N; Fort-Culillas R; Cruz CA; Perachino M; Yu T; et alii...

Is Medication-Related Osteonecrosis of the Jaws (MRONJ) Associated to Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors? A Word of Cautiousness. Comment on Marcianò et al. Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association. Int. J. Environ. Res. Public Health 2020, 17, 9509. in International journal of environmental research and public health / Int J Environ Res Public Health. 2021 Sep 27;18(19):10143. doi: 10.3390/ijerph181910143.

2021
AOU Alessandria
ASL Cuneo 2

Fusco V; Rossi M; Fasciolo A; Vincenti M; Guglielmini PF; Alessio M;

A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis. in Head & face medicine / Head Face Med. 2021 Jul 9;17(1):25. doi: 10.1186/s13005-021-00280-4.

2021
ASL Alessandria
AOU Alessandria

Bedogni A; Mauceri R; Fusco V; Bertoldo F; Campisi G;

The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols. in International journal of environmental research and public health / Int J Environ Res Public Health. 2021 Aug 10;18(16):8432. doi: 10.3390/ijerph18168432.

2021
AOU Alessandria

Campisi G; Tozzo P; Pizzo G; Fusco V; Bedogni A; Del Gaizo C; Mauceri R; Panzarella V; Canepa F; Di Fede O; Galvano A;

Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2021 Aug;29(8):4185-4186. doi: 10.1007/s00520-021-06100-4. Epub 2021 Feb 25.

2021
AOU Alessandria

Fusco V; Alessio M; Cabras M; Gambino A; Rossi M;

A multicenter observational study on medication-related osteonecrosis of the jaw (Mronj) in advanced cancer and myeloma patients of a cancer network in north-western italy in Medicina Oral Patologia Oral y Cirugia Bucal

2021
ASL Asti
ASL Alessandria
AOU Alessandria

Fasciolo A; Caka M; Migliario M; Franchi S; Gambino A; Fusco V; Cabras M; Erovigni F; Dell’acqua A; Arduino PG; Pentenero M; Appendino P; Basano L; Della Ferrera F;

Adjuvant denosumab in early breast-cancer. in The Lancet. Oncology / Lancet Oncol. 2020 Mar;21(3):e124. doi: 10.1016/S1470-2045(20)30066-8.

2020
ASL Alessandria
AOU Alessandria

Campisi G; Bedogni A; Fusco V;

Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary. in JCO oncology practice / JCO Oncol Pract. 2020 Mar;16(3):142-145. doi: 10.1200/JOP.19.00645. Epub 2020 Jan 24.

2020
ASL Alessandria
AOU Alessandria

Santini D; Fusco V; Campisi G; Bertoldo F; Lanzetta G; Ibrahim T; Bertetto O; Numico G; Addeo A; Berruti A; Bettini G; Saia G; Bedogni A;

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088). in Trials / Trials. 2020 Jul 25;21(1):678. doi: 10.1186/s13063-020-04568-9.

2020
AOU Alessandria
ASL Biella

Torri V; Orecchia S; Fusco V; Traverso E; Solaini L; Ercolani G; Cavaliere D; Buccianti P; Balestri R; Ceccarelli C; Coratti A; Menegatti B; Perna F; Contardo T; Mammano E; Morpurgo E; Pulighe F; De Nisco C; Pernazza G; Ruffo G; Alongi F; Bertocchi E; Gori S; Perinotti R; Rosati R; Delpini R; Boni L; Elmore U; Baldari L; et alii...

Correction to: Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2020 Feb 17;20(1):128. doi: 10.1186/s12885-020-6632-y.

2020
ASL Biella
AOU Alessandria
AOU Novara

Franzone P; Numico G; Priora F; Rossi M; Fusco V; Traverso E; Torri V; Cavaliere D; Solaini L; Ercolani G; Ceccarelli C; Balestri R; Buccianti P; Baroffio P; Gentilli S; Menegatti B; Coratti A; Perna F; Rosati R; Delpini R; Elmore U; Mammano E; Contardo T; Morpurgo E; Perinotti R; De Nisco C; Pulighe F; Pernazza G; Boni L; et alii...

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. in International journal of environmental research and public health / Int J Environ Res Public Health. 2020 Aug 18;17(16):5998. doi: 10.3390/ijerph17165998.

2020
AOU Alessandria

Bedogni A; Marchetti C; Vescovi P; Santarelli A; Romeo U; Panzarella V; Oteri G; Mignogna MD; Meleti M; Marcianò A; Mascitti M; Consolo U; Di Fede O; Favia G; Lo Muzio L; Lo Casto A; Fusco V; Gabriele M; Campisi G; Mauceri R; Bertoldo F; Bettini G; Biasotto M; Colella G;

Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2019 Dec 16;19(1):1215. doi: 10.1186/s12885-019-6271-3.

2019
ASL Biella
AOU Alessandria
AOU Novara

Orecchia S; Numico G; Franzone P; Priora F; Rossi M; Fusco V; Traverso E; Ercolani G; Cavaliere D; Solaini L; Torri V; Ceccarelli C; Buccianti P; Balestri R; Menegatti B; Gentilli S; Baroffio P; Perna F; Coratti A; Delpini R; Rosati R; Elmore U; Mammano E; Pulighe F; De Nisco C; Perinotti R; Morpurgo E; Boni L; Contardo T; et alii...

Inadequacy of current definition and staging system of Medication-Related Osteonecrosis of Jaw (MRONJ) released by AAOMS: A computed tomography study in 151 cancer and myeloma patients in Annals of Oncology

2019
AOU Alessandria

Fusco V; Fasciolo A; Gambino A; Cabras M; Erovigni F; Bianchi C; Benzi L; De Martino I; Monaco F; Rossi M; Numico G; Carossa S;

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. A Commentary of the Pivotal Trial by Raje et al. Published on Lancet Oncology. in Dentistry journal / Dent J (Basel). 2018 Sep 1;6(3):42. doi: 10.3390/dj6030042.

2018
ASL Alessandria
AOU Alessandria

Numico G; Bedogni A; Baraldi A; Monaco F; Fusco V; de Boissieu P; Campisi G;

Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questions. in Acta clinica Belgica / Acta Clin Belg. 2018 Apr;73(2):163-164. doi: 10.1080/17843286.2017.1389473. Epub 2017 Nov 7.

2018
ASL Alessandria
AOU Alessandria

Numico G; Fasciolo A; Alessio M; De Martino I; Rossi M; Fusco V;

To do or not to do the dental extraction in cancer patients, who receive bone targeted agents (BTAS): A systematic review, BSG, MASCC, part 1 in Supportive Care in Cancer

2018
AOU Alessandria

Vardas E; Nicolatou-Galitis O; Papadopoulou E; Kouri M; Galiti D; Torres S; Fusco V; Estilo C; Saunders D; Body JJ; Migliorati C; Lalla RV;

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition. in Dentistry journal / Dent J (Basel). 2017 Mar 16;5(1):13. doi: 10.3390/dj5010013.

2017
AOU Alessandria

Benzi L; Alessio M; Martino I; Vescovi P; Mergoni G; Migliario M; Renò F; Fusco V;

2017
AO Ordine Mauriziano
AOU Alessandria

Fusco V; Cabras M; Gambino A; Bertetto O; Numico G; De Martino I; Alessio M; Marinella M; Di Maio M; Baratelli C; Bironzo P; Vignani F; Bria E; Sperti E; Marcato M; Roila F;

Osteonecrosis of jaw (ONJ) after antiresorptive treatment (bisphosphonates, denosumab) of cancer-treatment induced bone loss (CTIBL): A negligible risk? in Annals of Oncology

2017
AOU Città della Salute di Torino
AOU Alessandria
ASL Cuneo 2

Gambino A; Cabras M; Fusco V; Bertetto O; De Martino I; Alessio M; Numico G; Cagnazzo C; Arizio F; Piccinni Leopardi M; Di Costanzo A; Crotto L; Matocci R; Lucarelli A; Grassi E; Saracino V; Fugazza C; Cinefra M; Marchetti F; Taverniti C; Stabile S; Monti M; Marchesi E;

Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases. in Dentistry journal / Dent J (Basel). 2016 Oct 29;4(4):39. doi: 10.3390/dj4040039.

2016
AOU Città della Salute di Torino
AOU Alessandria

Fusco V; Bianchi SD; Bellini E; Fasciolo A; Cabras M; Gambino A; Erovigni F;

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures. in Dentistry journal / Dent J (Basel). 2016 Dec 1;4(4):45. doi: 10.3390/dj4040045.

2016
AOU Alessandria

Catania G; Monaco F; Limberti G; Alessio M; De Martino I; Barile C; Fasciolo A; Baraldi A; Ladetto M; Fusco V;

Osteonecrosis of jaw (ONJ) with and without bone exposure in patients receiving antiangiogenic agents (+/-bisphosphonates or denosumab) in Annals of Oncology

2015
AOU Alessandria

Fusco V; Fasciolo A; Gaino R; Tartara D; De Martino I; Alessio M; Benzi L; Rapetti M; Cammarata R; Caravaggio E; Vincenti M; Gugliemini P;

Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents in Future Oncology

2014
ASL Alessandria
AOU Alessandria

Bedogni A; Di Fede O; Pizzo G; Fedele S; Fusco V; Campisi G;

Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures in Osteoporosis International

2013
AOU Alessandria

Mazzaglia G; Campisi G; Fusco V; Brandi M; Vestri A; Staniscia T; Carle F; Gregori D; Di Bari M; Sturkenboom MC; Lapi F; Cipriani F; Caputi AP; Corrao G; Vaccheri A;

Osteonecrosis of the jaw related to bisphosphonates, denosumab and anti-angiogenics in cancer and osteoporotic patients: Diagnosis and management in Dental Cadmos

2013
AOU Alessandria

Vescovi P; Di Fede O; Campisi G; Bedogni A; Lo Muzio L; Fusco V;

Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: A retrospective multi-hospital-based study of 87 Italian cases in European Journal of Internal Medicine

2013
AOU Alessandria

Campisi G; Colella G; Vescovi P; Sprini D; Peluso F; Favia G; Gaeta GM; Gabriele M; Solazzo L; Matranga D; Fusco V; Di Fede O;

Osteonecrosis of the jaw related to bisphosphonates, denosumab and anti-angiogenics in cancer and osteoporotic patients: Prevention and safety of dental procedures in Dental Cadmos

2013
AOU Alessandria

Muzio LL; Fusco V; Vescovi P; Bedogni A; Fede OD; Campisi G;

Adding imaging to the clinical picture improves BRONJ case adjudication and staging classification: Results of the “MISSION” study in European Journal of Cancer

2013
AOU Alessandria

Bedogni A; Fusco V; Scoletta M; Saia G; Colella G; Favia G; Agrillo A; Oteri G; Ottolenghi L; Campisi G;

Role of bone scan in routine practice for early recognition of bisphosphonate-related osteonecrosis of the jaws (ONJ): Pro and con in Journal of Clinical Oncology

2013
AOU Alessandria

Fusco V; Tommasi L; Muni A; Rouhanifar H; Testori O; Fasciolo A; Benzi L; De Martino I; Randi L; Guglielmini PF; Pertino A;

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: Results from the NEMESI study in BMC Cancer

2012
AOU Alessandria

Venturini M; Dondi D; Altavilla G; Gamucci T; Baldini E; Fusco V; Alabiso O; Graiff C; Molino A; Giordano M; Tarenzi E; Foglietta J; Siena S; Clavarezza M; Gori S;

Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ) in Oral Diseases

2012
AOU Alessandria

Agrillo A; Fusco V; Bedogni A; Campisi G;

Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients in Oncology Reports

2011
AOU San Luigi di Orbassano
AOU Alessandria

Santini D; Vincenzi B; Adamo V; Addeo R; Fusco V; Russo A; Montemurro F; Roato I; Redana S; Lanzetta G; Satolli MA; Berruti A; Leoni V; Galluzzo S; Antimi M; Ferraro G; Del Salvatore P; Valerio MR; Marra M; Caraglia M; Tonini G;

Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment in Breast

2010
AOU Alessandria

Fusco V; Loidoris A; Colella G; Vescovi P; Campisi G;

Bisphosphonate related osteonecrosis of the jaws in Journal of Rheumatology

2009
AOU Alessandria

Fedele S; Campisi G; Fusco V; Lo Casto A; Colella G;